Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-16-001230
Filing Date
2016-02-16
Accepted
2016-02-16 16:19:55
Documents
1
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT, LLCCORMORANT GLOBAL HEALTHCARE GP, LLC

Document Format Files

Seq Description Document Type Size
1 a69987.htm SC 13G/A 98671
  Complete submission text file 0000929638-16-001230.txt   100535
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39444 | Film No.: 161428623
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Filed by) CIK: 0001618442 (see all company filings)

EIN.: 981101801 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A